Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
29 results
D1.16 - Molecular sensitization profiles in house dust mite allergic patients from Valencian Community
D1.18 - Comparative Analysis of Nasal Secretions and Serum Biomarkers in House Dust Mite Allergy: Correlation with Symptoms and Skin Prick Test Results
D1.19 - Contribution of Panallergens to Edible Insect Reactivity in Mite-Sensitized Individuals
D1.20 - Progesterone-Induced Urticaria: Diagnostic and Therapeutic Approach
D1.22 - Molecular Allergen Sensitization Patterns in Cat, Dog and Horse Allergies in Children
D1.23 - Unrestricted Potential: The Role of AMS in Tackling Allergy Labels
D1.24 - Towards risk assessment of peanut sensitised patients based on statistical modelling of 32,500 IgE-macroarray test results
D1.25 - Clinical Characteristics of Chronic Urticaria in Adults Under 45 Years Old with Vitamin D Insufficiency
D2.82 - Association between additional corticosteroid usage and Uncontrolled Severe Asthma: A Retrospective Study Using the China Regional Database
D2.83 - Correct Inhaler Technique as a Key Element of Asthma Management: Post-Education Evaluation of Patients' Knowledge
D2.84 - Heterogeneity of Elderly Asthma: a nationwide health and nutrition examination survey
D2.85 - Living a Normal Life with Asthma: Development of a Conceptual Model
D2.86 - Characteristics of Severe type 2 Asthma Patients in China: A Retrospective Observational Study
D2.87 - Disease Burden of Severe Asthma Patients Treated with Medium and High Doses of ICS: A Regional Database Analysis from China
D2.89 - Investigation of Asthma Characteristics in Women with Generalized Periodontitis and Polycystic Ovary Syndrome
D2.90 - Decrease in New-Onset Asthma During the COVID-19 Pandemic
D2.91 - Distribution of Patients with Asthma According to the New Immune Response Classification
D2.92 - Comparison of responsiveness to bronchodilators using the 2021 or 2005 ATS/ERS guidelines: bicenter retrospective study
D2.93 - Differential effects of dupilumab in women with severe uncontrolled asthma
D2.94 - Loss of lung function at 5 years in patients with asthma: DECLIVEMS study
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download